BEVERLY, Mass - BioHelix announced today that it has been awarded a two-year phase 1 SBIR Advanced Technology grant from the National Institutes of Health to develop rapid diagnostic tests for Malaria parasites.
The project, which is a collaborative effort between BioHelix and Tulane University School of Public Health and Tropical Medicine, involves the development of rapid detection method for malaria in blood using BioHelix's IsoAmp® platform which consists of HDA isothermal amplification and instrument-free detection with a disposable cassette. Dr. Nirbhay Kumar, Professor and Chair of Department of Tropical Medicine at Tulane University, is directing the Tulane effort.
"The IsoAmp® system is ideally suited to this type of test because of its ability to amplify and detect malaria DNA in the blood without sample-prep. This ability will allow rapid, nucleic acid analysis of different species of malaria parasites. Scheduled for market availability in 2011, the IsoAmp® system is designed to provide a simple-to-use and cost-effective molecular diagnostic solution to laboratories around the world," said Huimin Kong, BioHelix president and CEO.
Dr. Kumar said, "Rapid diagnosis of malaria will save many precious lives by allowing timely treatment. BioHelix's technology is ideally suited to this project. Our goal is to develop a diagnostic system for malaria that can be used anywhere in the world by individuals with minimal training."